Multiplex PCR-Based Newborn Screening for Severe T and B-Cell Lymphopenia: The first Pilot Study in Turkey

Objective & Hypothesis:Objectives: Severe combined immunodeficiency disease (SCID), non-SCID T-cell lymphopenia, and other primary immunodeficiency diseases with T-cell and B-cell lymphopenia have low the T-cell-receptor-excision circles (TRECs) and κ-deleting-recombinationexcision circles (KRECs) levels that can be measured in dried blood spots (DBS) of the newborn.

📊

Key Findings & Data:The incidence of SCID and non-SCID T-cell lymphopenia in Western societies has been reported by TREC screening of newborns as 1: 58,000 and 1: 7300, respectively.

💡

Conclusion & Impact:Studies involving more newborns should be conducted to detect SCID.

🔬Design:Research Article

📍Scope:2015 Verileri

⚙️Variables:Domain Parameters

Özet

Objectives: Severe combined immunodeficiency disease (SCID), non-SCID T-cell lymphopenia, and other primary immunodeficiency diseases with T-cell and B-cell lymphopenia have low the T-cell-receptor-excision circles (TRECs) and κ-deleting-recombinationexcision circles (KRECs) levels that can be measured in dried blood spots (DBS) of the newborn. The incidence of SCID and non-SCID T-cell lymphopenia in Western societies has been reported by TREC screening of newborns as 1: 58,000 and 1: 7300, respectively. Since there is no similar study in our country, we aimed to perform the first pilot study of TREC and KREC screening of newborn for SCID and non-SCID T-cell lymphopenia in Turkey. Methods: The heel blood samples of newborns born between 1st October 2015 and 31st December 2016 at two major hospitals in our city were included in this study. TREC and KREC copies were determined by a multiplex quantitative PCR-based method from newborn DBS. Cutoff levels were used as 7 copies per DBS for TRECs and KRECs, 1000 copies for ACTB (internal control). Failed samples or abnormal results in measurements were tested the second time. An immunologist evaluated data of newborns with low TREC and KREC copies clinically and through the laboratory. Results: A total of 1960 DBS were tested. The results of 1856 newborns were evaluated. The low TRECs and/or KRECs levels were detected in 71 newborns (3.8 %). The low TRECs rate was 1.1 %. Preterm newborns have lower levels of TRECs and KRECs than term newborns (both p <0.0001). As a result of immunological research, we did not detect any SCID, but we detected 2 newborns with non-SCID T-cell lymphopenia (1:928). These 2 newborns were found to have frequent and severe infectious diseases or hypogammaglobulinemia in their clinical follow-up, although they did not have absolute lymphopenia. Conclusion: Non-SCID T-cell lymphopenia is common in our country than in western societies. TRECs and KRECs assay should be considered for routine NBS programs in our country. Studies involving more newborns should be conducted to detect SCID.

🔖

Cite This Article

KUTLUG, S., ALPASLAN, M. K., HANCİOGLU, G., OZKAN, S. E. O., YESİLİRMAK, D. C., BULUT, H., AYGUN, C., OGUR, G., YİLDİRAN, A. (2021). Multiplex PCR-Based Newborn Screening for Severe T and B-Cell Lymphopenia: The first Pilot Study in Turkey. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 4, [551]–559. https://ajindex.com/articles/399599

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al.; International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol 2018; 38:96–128
King JR, Hammarström L.; Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. J Clin Immunol 2018;38(1):56-66
Puck JM.; Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol Rev 2019;287(1):241- 252. 4. van der Burg M, Mahlaoui N, Gaspar HB, Pai SY.; Universal Newborn Screening for Severe Combined Immunodeficiency (SCID). Front Pediatr 2019;18(7):373
Dorsey MJ, Dvorak CC, Cowan MJ, Puck JM.; Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening. J Allergy Clin Immunol 2017;139(3):733-742
Wilson JM, Jungner YG.; Principles and practice of mass screening for disease. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 1968;65(4):281‐393
Borte S, Von Dobeln, U, Fasth A, Wang N, Janzi M, Winiarski J, Sack U, Pan-Hammarstrom Q, Borte M, Hammarstrom L.; Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012;119: 2552–5
Borte S, Von Döbeln U, Hammarström L.; Guidelines for newborn screening of primary İmmuno deficiency diseases. Curr Opin Hematol 2013; 20(1): 48-54
Chan K, Puck JM.; Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2005;115(2):391–8. 10. van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ.; Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 2007;204
Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al.; Quantification of kappa-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol 2011;128(1):223–5. e2 12. El-Sayed ZA, Radwan N.; Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries. Front Immunol 2020;10:2987
Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al.; Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014;312:729–38. 14. de Felipe B, Olbrich P, Lucenas JM, et al.; Prospectiv